首页> 外文OA文献 >PRS4 COST OF TREATMENT AND REIMBURSEMENT OF HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA WITH I.V. MOXIFLOXACIN COMPARED TO STANDARD ANTIBIOTIC TREAMENT IN GERMANY

【2h】

PRS4 COST OF TREATMENT AND REIMBURSEMENT OF HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA WITH I.V. MOXIFLOXACIN COMPARED TO STANDARD ANTIBIOTIC TREAMENT IN GERMANY

机译：PRS4静脉内治疗社区获得性肺炎的治疗和恢复费用莫西沙星与德国标准抗生素治疗相当

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
De Zeeuw J; Pfeil T; Thate-Waschke IM; Ernen C; Daniel D; Bauer TT; Schlosser BM; Rychlik R;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment [J] . Finch R, Schurmann D, Collins O, Antimicrobial agents and chemotherapy. . 2002,第6期

机译：序贯静脉内（i.v.）和口服莫西沙星与序贯静脉内（i.v.）比较的随机对照试验需要初始肠胃外治疗的社区获得性肺炎患者的口服和口服阿莫昔芬联合或不联合克拉霉素
2. A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial. [J] . Lloyd A, Holman A, Evers T Current medical research and opinion . 2008,第5期

机译：在德国进行的费用最小化分析比较莫西沙星与左氧氟沙星加头孢曲松治疗社区获得性肺炎的患者：MOTIV试验的结果。
3. A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial. [J] . Lloyd A, Holman A, Evers T Current medical research and opinion . 2008,第5期

机译：在德国进行的费用最小化分析比较莫西沙星与左氧氟沙星加头孢曲松治疗社区获得性肺炎的患者：MOTIV试验的结果。
4. Atosiban Is Cost Saving Compared to Beta-Mimetics in the Treatment of Preterm Labour in Germany [C] . J. Wex, M. Connolly, D. Schneider, European Congress of Perinatal Medicine . 2008

机译：与β模仿在德国早产劳动中的β模仿相比，阿特塞利亚是节省成本的
5. Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment [O] . R. Finch, D. Schürmann, O. Collins, 2002

机译：序贯静脉（i.v.）和口服莫西沙星与序贯i.v.的随机对照试验需要初始肠胃外治疗的社区获得性肺炎患者的口服和口服阿莫昔芬联合或不联合克拉霉素
6. PRS2 A COST-MINIMIZATION ANALYSIS COMPARING MOXIFLOXACIN VERSUS LEVOFLOXACIN AND CEFTRIAXONE FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA: RESULTS FROM THE MOTIVTRIAL [O] . Lloyd AC, Hoi man AJ 2007

机译：PRS2莫西沙星与左氧氟沙星和头孢曲松钠比较治疗社区获得性肺炎住院患者的成本最小化分析：来自城市的结果

PRS4 COST OF TREATMENT AND REIMBURSEMENT OF HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA WITH I.V. MOXIFLOXACIN COMPARED TO STANDARD ANTIBIOTIC TREAMENT IN GERMANY

著录项

引文网络

相似文献

相关主题

期刊订阅